AMG

Amgen is one of the world's largest independent biotechnology companies, focusing on human therapeutics for serious illnesses with limited treatment options. The company specializes in oncology, inflammation, cardiovascular disease, nephrology, and bone health, utilizing advanced human genetics to unravel the complexities of disease. Amgen is well-known for its pioneering work in biologics and its proprietary BiTE (Bispecific T-cell Engager) platform, which directs the immune system to target cancer cells. Its commercial portfolio includes blockbuster drugs such as Enbrel, Prolia, and Repatha, while its robust pipeline continues to advance novel modalities like siRNA and multispecific antibodies.